UPDATE: Oppenheimer Starts Trevi Therapeutics (TRVI) at Outperform
Tweet Send to a Friend
(Updated - May 24, 2022 4:02 PM EDT)
Oppenheimer analyst Leland Gershall initiates coverage on Trevi Therapeutics (NASDAQ: TRVI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershall initiates coverage on Trevi Therapeutics (NASDAQ: TRVI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
